Alex Bell
Impact in
-
- Drug Transport and Resistance Mechanisms
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Adipose Tissue and Metabolism 3
- Co-authors
- Ruth RobertsHoward R. MellorJean‐Pierre ValentinAnnabelle HeierMark J. AndertonSteve PowellC SadlerMartin Pass
- Journals
- Toxicological Sciences (1 paper)Experimental and Toxicologic Pathology (1 paper)Toxicologic Pathology (1 paper)FEBS Letters (1 paper)Xenobiotica (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Alex Bell
12 papers receiving 621 citations
Peers
Comparison fields: 5 of 82
- Oncology 189
- Cardiology and Cardiovascular Medicine 119
- Molecular Biology 354
- Pharmacology 43
- Cancer Research 59
Countries citing papers authored by Alex Bell
This map shows the geographic impact of Alex Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Bell more than expected).
Fields of papers citing papers by Alex Bell
This network shows the impact of papers produced by Alex Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Bell. The network helps show where Alex Bell may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Bell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 211 | |
| 2 | 2010 | 128 | |
| 3 | 2008 | 13 | |
| 4 | 2007 | 30 | |
| 5 | 2006 | 5 | |
| 6 | 2005 | 8 | |
| 7 | 2003 | 28 | |
| 8 | 2002 | 25 | |
| 9 | 2000 | 42 | |
| 10 | 1998 | 58 | |
| 11 | 1995 | 62 | |
| 12 | 1987 | 27 |
About Alex Bell
Alex Bell is a scholar working on Physiology, Immunology and Allergy, Biochemistry, Statistics and Probability and Molecular Biology, having authored 12 papers that have together received 637 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Effects and risks of endocrine disrupting chemicals (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and Respiratory and Cough-Related Research (1 paper). The work is most often cited by research in Oncology (189 citations), Cardiology and Cardiovascular Medicine (119 citations), Molecular Biology (354 citations), Pharmacology (43 citations) and Cancer Research (59 citations). Alex Bell has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ruth Roberts, Howard R. Mellor, Jean‐Pierre Valentin, Annabelle Heier, Mark J. Anderton, Steve Powell, C Sadler, Martin Pass, David Bell and Tim J.B. Gray. Their work appears in journals such as Toxicological Sciences, Experimental and Toxicologic Pathology, Toxicologic Pathology, FEBS Letters and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.